Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ostchega

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|November 1, 1982
Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol bindingF P Abramson, J Jenkins, Y Ostchega
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
High-dose carboplatin in refractory ovarian cancer patientsR F Ozols, Y Ostchega, G Curt, et al.
Journal of Human Hypertension|September 10, 2005
Tables for the selection of correct blood pressure cuff size based on self-reported height and weight and estimating equations for mid-arm circumference: data from the US National Health and Nutrition Examination SurveyY Ostchega, C Dillon, R J Prineas, et al.
Journal of Human Hypertension|July 1, 2005
US demographic trends in mid-arm circumference and recommended blood pressure cuffs: 1988-2002Y Ostchega, C Dillon, M Carroll, et al.
Cancer Treatment Reviews|September 1, 1985
High dose cisplatin and high dose carboplatin in refractory ovarian cancerR F Ozols, B C Behrens, Y Ostchega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
High-dose cisplatin in hypertonic saline in refractory ovarian cancerR F Ozols, Y Ostchega, C E Myers, et al.
Cancer Treatment Reports|July 1, 1983
MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicityR F Ozols, W M Hogan, Y Ostchega, et al.
Journal of the American Geriatrics Society|September 13, 2000
The prevalence of functional limitations and disability in older persons in the US: data from the National Health and Nutrition Examination Survey IIIY Ostchega, T B Harris, R Hirsch, et al.
Cancer Nursing|August 1, 1990
Self-assessed learning needs of oncology nurses caring for individuals with HIV-related disorders. A national surveyJ G Jacob, Y Ostchega, C Grady, et al.
Journal of the American Geriatrics Society|September 13, 2000
Reliability and prevalence of physical performance examination assessing mobility and balance in older persons in the US: data from the Third National Health and Nutrition Examination SurveyY Ostchega, T B Harris, R Hirsch, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|November 1, 1982
Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol bindingF P Abramson, J Jenkins, Y Ostchega
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
High-dose carboplatin in refractory ovarian cancer patientsR F Ozols, Y Ostchega, G Curt, et al.
Journal of Human Hypertension|September 10, 2005
Tables for the selection of correct blood pressure cuff size based on self-reported height and weight and estimating equations for mid-arm circumference: data from the US National Health and Nutrition Examination SurveyY Ostchega, C Dillon, R J Prineas, et al.
Journal of Human Hypertension|July 1, 2005
US demographic trends in mid-arm circumference and recommended blood pressure cuffs: 1988-2002Y Ostchega, C Dillon, M Carroll, et al.
Cancer Treatment Reviews|September 1, 1985
High dose cisplatin and high dose carboplatin in refractory ovarian cancerR F Ozols, B C Behrens, Y Ostchega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
High-dose cisplatin in hypertonic saline in refractory ovarian cancerR F Ozols, Y Ostchega, C E Myers, et al.
Cancer Treatment Reports|July 1, 1983
MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicityR F Ozols, W M Hogan, Y Ostchega, et al.
Journal of the American Geriatrics Society|September 13, 2000
The prevalence of functional limitations and disability in older persons in the US: data from the National Health and Nutrition Examination Survey IIIY Ostchega, T B Harris, R Hirsch, et al.
Cancer Nursing|August 1, 1990
Self-assessed learning needs of oncology nurses caring for individuals with HIV-related disorders. A national surveyJ G Jacob, Y Ostchega, C Grady, et al.
Journal of the American Geriatrics Society|September 13, 2000
Reliability and prevalence of physical performance examination assessing mobility and balance in older persons in the US: data from the Third National Health and Nutrition Examination SurveyY Ostchega, T B Harris, R Hirsch, et al.
Pageof 2